Condition (MeSH)
Babesiosis
ClinicalTrials.gov lists 4 trials for Babesiosis or a narrower condition beneath it. 60 Degrees Pharmaceuticals LLC has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
4 of the 4 trials are tagged with Babesiosis itself; the rest are tagged with a narrower condition beneath it.
When did Babesiosis trials start? (3)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 1 |
| 2024 | 2 |
| 2021 | 1 |
No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Babesiosis trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Observational | 3 |
How many Babesiosis trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 2 |
| Withdrawn | 1 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Babesiosis trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| 60 Degrees Pharmaceuticals LLC | 1 |
Which publications cover Babesiosis? (7)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Screening for Babesia microti in the U.S. Blood Supply. | The New England journal of medicine | 2016 | Yes |
| Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay. | Transfusion | 2014 | Yes |
| The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2006 | Yes |
| First documented case of human babesiosis in Sweden. | Scandinavian journal of infectious diseases | 1992 | Yes |
| Protection of mice against Babesia and Plasmodium with BCG. | Nature | 1976 | Yes |
Showing 5 of 7 publications.
Prevalence (3)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Babesiosis | Point prevalence | <1 / 1 000 000 | Europe | Not stated | Exact |
| Babesiosis | Point prevalence | <1 / 1 000 000 | Europe | Not stated | Exact |
| Babesiosis | Point prevalence | <1 / 1 000 000 | Europe | Not stated | Unspecified |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Babesiosis | 108 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Babesiosis | 108 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.